Combined Cognitive-Behavioural Therapy and Pharmacotherapy for Adolescent Depression: Does it Improve Outcomes Compared with Monotherapy?

Author： Vitiello Benedetto  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.4, 2009-01, pp. : 271-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SSRIs in conjunction with cognitive behavioural therapy (CBT), compared with an SSRI alone, do not improve outcomes for children and adolescents with moderate-to-severe depression

By  

Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Does guideline adherence improve antibacterial therapy?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?

By Tedesco M.A.   Ratti G.   Di Salvo G.   Natale F.  

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?

By Demchuk Andrew M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1833-1845

Adis International

Access to resources Recommend Favorite

Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer?

By Ebbert Jon O.   Hays J. Taylor   Hurt Richard D.  

Drugs, Vol. 70, Iss. 6, 2010-04 ,pp. : 643-650

Adis International

Access to resources Recommend Favorite